
Bionano Genomics, Inc.: updates and filings
Price
$0.82
November 20, 2026Market cap $12M
What Ploutos Investor adds for Bionano Genomics
Part of Ploutos Investor, €9.99 a month
- The full history: 9 fiscal years, from 2017
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The share price has fallen 28% since Nov 10, 2026, when the 10-Q these figures come from was filed ($1.23 then, $0.89 on Nov 19, 2026). The figures date from before that move.10-Q
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Nov 10, 2026next Feb 11, 2027
An estimate from when it has reported before, which has been regular. The company announces the date itself.
November 2026
August 2026
May 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 16, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Nov 10, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Nov 10, 2026Results of operationsForm8-K
- Nov 5, 2026FilingFormEFFECT
- Nov 5, 2026FilingFormEFFECT
- Nov 2, 2026Shelf registration for future offerings (amendment)FormS-3/A
- Oct 27, 2026FilingFormS-1
- Oct 19, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Sep 14, 2026Regulation FD disclosureForm8-K
- Aug 14, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Aug 10, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Aug 10, 2026Results of operationsForm8-K
- Jun 24, 2026Other material eventsForm8-K
- Jun 5, 2026Officer or director changeForm8-K
- May 28, 2026Other material eventsForm8-K
- May 14, 2026Shareholder voteForm8-K
- May 13, 2026Quarterly reportfor the period to Mar 31, 2026Form10-Q
- May 13, 2026Results of operationsForm8-K
- May 8, 2026Shelf registration for future offeringsFormS-3
- May 6, 2026Officer or director change, other material eventsForm8-K
- Apr 2, 2026Annual report to shareholdersfor the period to Dec 31, 2025FormARS
- Apr 2, 2026Additional annual meeting materialFormDEFA14A
- Apr 2, 2026Annual meeting proxy statementFormDEF 14A
- Mar 25, 2026Shares registered for employeesFormS-8
- Mar 23, 2026Annual reportfor the period to Dec 31, 2025Form10-K
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 16, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Nov 10, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Nov 10, 2026 | 8-K | Results of operations | Document |
| Nov 5, 2026 | EFFECT | Filing | Document |
| Nov 5, 2026 | EFFECT | Filing | Document |
| Nov 2, 2026 | S-3/A | Shelf registration for future offerings (amendment) | Document |
| Oct 27, 2026 | S-1 | Filing | Document |
| Oct 19, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Sep 14, 2026 | 8-K | Regulation FD disclosure | Document |
| Aug 14, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Aug 10, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Aug 10, 2026 | 8-K | Results of operations | Document |
| Jun 24, 2026 | 8-K | Other material events | Document |
| Jun 5, 2026 | 8-K | Officer or director change | Document |
| May 28, 2026 | 8-K | Other material events | Document |
| May 14, 2026 | 8-K | Shareholder vote | Document |
| May 13, 2026 | 10-Q | Quarterly reportfor the period to Mar 31, 2026 | Document |
| May 13, 2026 | 8-K | Results of operations | Document |
| May 8, 2026 | S-3 | Shelf registration for future offerings | Document |
| May 6, 2026 | 8-K | Officer or director change, other material events | Document |
| Apr 2, 2026 | ARS | Annual report to shareholdersfor the period to Dec 31, 2025 | Document |
| Apr 2, 2026 | DEFA14A | Additional annual meeting material | Document |
| Apr 2, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| Mar 25, 2026 | S-8 | Shares registered for employees | Document |
| Mar 23, 2026 | 10-K | Annual reportfor the period to Dec 31, 2025 | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Aug 31, 2007.
The full analysis
What do Bionano Genomics's filings show?
The filings are where every one of Bionano Genomics's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.